1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Panaxia Labs Israel Ltd
  6. News
  7. Summary
    PNAX   IL0011043630

PANAXIA LABS ISRAEL LTD

(PNAX)
  Report
End-of-day quote TEL AVIV STOCK EXCHANGE  -  05-24
0.5900 ILS   -3.28%
03/31Panaxia Labs Israel Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about PANAXIA LABS ISRAEL LTD
03/31Panaxia Labs Israel Ltd Reports Earnings Results for the Full Year Ended December 31, 2..
CI
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Third Quarter and Nine Months ..
CI
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Second Quarter Ended June 30, ..
CI
2021Panaxia Labs Israel Ltd. and Neuraxpharm Expands Strategic Collaboration to Poland
CI
2021IMC Holdings Ltd. agreed to acquire Israel's Largest Retail and Online Pharmacy Busines..
CI
2021Panaxia Labs Israel Ltd Provides Revenue Guidance for the First Quarter of 2021
CI
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Fourth Quarter and Year 2020
CI
2021Government of Cyprus Selects Panaxia Labs Israel Ltd. to Supply Premium Oils
CI
2021Neuraxpharm France and Panaxia Labs Select the Participation in A Pilot Program for the..
CI
2020Panaxia Labs Israel Ltd Reports Revenue Results for the Third Quarter and Nine Months o..
CI
2020Panaxia Labs Israel Ltd. and Neuraxpharm to Receive A Marketing Permit for Medical Cann..
CI
2020Panaxia Labs Israel Ltd announced that it has received ILS 17 million in funding
CI
2020Panaxia Labs Israel Ltd Provides Revenue Guidance for the Third Quarter and Nine Months..
CI
2020Panaxia Labs Israel Ltd Reports Financial Results for the Second Quarter and First Half..
CI
2020Canveda Inc. Enters into Production and Distribution Agreement with Panaxia Pharmaceuti..
CI
More most relevant news
All news about PANAXIA LABS ISRAEL LTD
03/31Panaxia Labs Israel Ltd Reports Earnings Results for the Full Year Ended December 31, 2..
CI
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Third Quarter and Nine Months ..
CI
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Second Quarter Ended June 30, ..
CI
2021Panaxia Labs Israel Ltd. and Neuraxpharm Expands Strategic Collaboration to Poland
CI
2021IM Cannabis Corp.
AQ
2021IMC Holdings Ltd. agreed to acquire Israel's Largest Retail and Online Pharmacy Busines..
CI
2021Panaxia Labs Israel Ltd Provides Revenue Guidance for the First Quarter of 2021
CI
2021Panaxia Labs Israel Ltd Reports Earnings Results for the Fourth Quarter and Year 2020
CI
2021Government of Cyprus Selects Panaxia Labs Israel Ltd. to Supply Premium Oils
CI
2021Neuraxpharm France and Panaxia Labs Select the Participation in A Pilot Program for the..
CI
More news
News in other languages on PANAXIA LABS ISRAEL LTD
03/31Panaxia Labs Israel Ltd publie ses résultats financiers pour l'année complète se termin..
2021Panaxia Labs Israel Ltd fournit des prévisions de revenus pour le premier trimestre de ..
2020Panaxia Labs Israel Ltd fournit des prévisions de revenus pour le troisième trimestre e..
2020Panaxia Labs Israel Ltd. fournit des prévisions de revenus préliminaires pour le deuxiè..
More news
Press releases
2021IM Cannabis Corp.
AQ
More press releases
Upcoming event on PANAXIA LABS ISRAEL LTD